These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19723460)

  • 21. Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome.
    Capomolla S; Febo O; Opasich C; Guazzotti G; Caporotondi A; La Rovere MT; Gnemmi M; Mortara A; Vona M; Pinna GD; Maestri R; Cobelli F
    Eur J Heart Fail; 2001 Oct; 3(5):601-10. PubMed ID: 11595609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis.
    Khot UN; Novaro GM; Popović ZB; Mills RM; Thomas JD; Tuzcu EM; Hammer D; Nissen SE; Francis GS
    N Engl J Med; 2003 May; 348(18):1756-63. PubMed ID: 12724481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Right ventricular-vascular interaction in congestive heart failure. Importance of low-frequency impedance.
    Kussmaul WG; Altschuler JA; Matthai WH; Laskey WK
    Circulation; 1993 Sep; 88(3):1010-5. PubMed ID: 8353862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasodilator therapy in cardiac failure what was new is old.
    O'Rourke MF; Nichols WW
    J Am Coll Cardiol; 2009 Mar; 53(10):898; discussion 898-99. PubMed ID: 19264253
    [No Abstract]   [Full Text] [Related]  

  • 25. The treatment targets in acute decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S7-S12. PubMed ID: 12439356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.
    Mikulic E; Cohn JN; Franciosa JA
    Circulation; 1977 Oct; 56(4 Pt 1):528-33. PubMed ID: 902377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL; Cohn JN; Franciosa JA
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
    Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
    J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
    Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
    Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A
    Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure.
    Amin DK; Shah PK; Hulse S; Shellock F
    Am Heart J; 1985 May; 109(5 Pt 1):1006-12. PubMed ID: 3158182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects of oral ephedrine given alone or combined with nitroprusside infusion in patients with severe left ventricular failure.
    Franciosa JA; Cohn JN
    Am J Cardiol; 1979 Jan; 43(1):79-85. PubMed ID: 758774
    [No Abstract]   [Full Text] [Related]  

  • 34. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
    Packer M; Medina N; Yushak M
    Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination vasodilator therapy for severe chronic congestive heart failure.
    Chatterjee K; Drew D; Parmley WW; Klausner SC; Polansky J; Zacherle B
    Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasodilator therapy for decompensated heart failure.
    Yancy CW
    J Am Coll Cardiol; 2008 Jul; 52(3):208-10. PubMed ID: 18617069
    [No Abstract]   [Full Text] [Related]  

  • 37. Vasodilators in the management of acute heart failure.
    Elkayam U; Janmohamed M; Habib M; Hatamizadeh P
    Crit Care Med; 2008 Jan; 36(1 Suppl):S95-105. PubMed ID: 18158484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
    Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
    Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination.
    Ribner HS; Zucker MJ; Stasior C; Talentowski D; Stadnicki R; Lesch M
    Am Heart J; 1987 Jul; 114(1 Pt 1):91-6. PubMed ID: 3604877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic effects of sodium nitroprusside in patients with ventricular septal defect.
    Subramanyam R; Tandon R; Shrivastava S
    Eur J Pediatr; 1982 Jul; 138(4):307-10. PubMed ID: 7128637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.